Skip to content

Agilon Health AGL 12 months or more

12 months or more at other companies

CVS Health logo
CVS HealthCVS

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's 12 months or more.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's 12 months or more?
Agilon Health (AGL) reported 12 months or more of $0 in Q4 2025.
How has Agilon Health's 12 months or more changed year-over-year?
Agilon Health's 12 months or more decreased by 100.0% year-over-year, from $111.92M to $0.
What is the long-term trend for Agilon Health's 12 months or more?
Over 2 years (2023 to 2025), Agilon Health's 12 months or more has grown at a -100.0% compound annual growth rate (CAGR), from $202.17M to $0.